Tuberculosis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Within the TB-DM group, those known to be diabetic before incident TB (KDM) exhibited significantly higher levels of MMP-1, - 2, - 10 and - 12 at baseline and of MMP-1 and -3 post-treatment compared to those newly diagnosed with DM (NDM).
|
30045688 |
2018 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
We also tested whether inhibition of endogenous matrix metalloproteinase-1 (MMP-1) may inhibit cavitation during tuberculosis.
|
29554286 |
2018 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
MMP-1 plays a curial role in extracellular matrix degradation during the progression of tuberculosis.
|
28129430 |
2017 |
Tuberculosis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In mice, transgenic expression of human matrix metalloproteinase 1 causes caseous necrosis, the pathological hallmark of human tuberculosis.
|
25676469 |
2015 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Targeted siRNA studies identified the p110α isoform as key causing 5-fold increase in TB network-dependent MMP-1 secretion to 4900 ± 1100 pg/ml.
|
24076964 |
2014 |
Tuberculosis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Monocyte-microglial network-dependent MMP-1 and MMP-3 gene expression and secretion are dependent upon p38 MAPK in tuberculosis. p38 is therefore a potential target for adjuvant therapy in CNS TB.
|
23978194 |
2013 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
STAT3, p38 MAPK, and NF-kappaB drive unopposed monocyte-dependent fibroblast MMP-1 secretion in tuberculosis.
|
19915152 |
2010 |
Tuberculosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We report that a joint effect between the -2518 MCP-1 genotype GG and the -1607 MMP-1 genotype 2G/2G consistently increases the odds of developing TB 3.59-fold in Mexicans and 3.9-fold in Peruvians.
|
20111728 |
2010 |
Tuberculosis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and -3 expression and secretion via NF-kappaB- and Activator Protein-1-dependent monocyte networks.
|
20483790 |
2010 |
Tuberculosis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In summary, p-aminosalicyclic acid decreases MMP-1 activity by inhibiting a p38 MAPK-PG signaling cascade, suggesting that this pathway is a therapeutic target to reduce inflammatory tissue destruction in tuberculosis.
|
19380835 |
2009 |
Tuberculosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
1G genotypes of MMP-1 polymorphism, containing at least one 1G allele, were associated with the presence of endobronchial TB.
|
17996495 |
2008 |
Tuberculosis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
MMP-1 but not MMP-7 expression and secretion are relatively M. tuberculosis specific, are not upregulated by tuberculosis-associated cytokines, and are prostaglandin dependent.
|
16141443 |
2005 |
Tuberculosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Although MMP-1 polymorphism was not associated with onset risk of sarcoidosis and tuberculosis, the clinical characteristics of both diseases were affected by this polymorphism.
|
15127970 |
2004 |